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Abstract 
The incidence of gastrointestinal diseases and in particular gastric cancer (GC) is high worldwide. 
Over the last few years, numerous studies have speculated that Helicobacter pylori (H. pylori) and 
Epstein-Barr virus (EBV) can be correlated with gastric cancerogenesis.  
Virulence factors of H. pylori can contribute to the variability of clinical outcomes: among the 
most important virulence factors is the pathogenicity island (CagPAI), vacA and oipA gene. EBV 
infection usually persists in B cells and induces an inflammatory reaction in cooperation with H. 
pylori. In Sicily, H. pylori and EBV infections are particularly prevalent, and to our knowledge no 
study has addressed this yet. The aim of our study was to examine the association of H. pylori and 
EBV infection in patients with gastric diseases in Sicily. Gastric biopsies were collected from 24 
adult patients with chronic gastritis active (CGA) and from 24 adult patients without any gastric 
disease (NGD) who underwent upper gastrointestinal endoscopy. H. pylori infection was diagnosed 
by PCR for ureaseA gene while EBV-DNA was detected by Real time PCR for region Bam HI-W. 
Moreoever, we investigated the presence of CagPaI and the status of vacA and oipA genes. 
Percentage of resistance to Clarithromycin of H. pylori was evaluated also. We established that H. 
pylori and EBV infection was present in 42% of patients, while dual infection with H. pylori and 
EBV-DNA was present in 54% of the patients with CGA. In patients with NGD we found that H. 
pylori and EBV infection was present in 46% and in 21% of patients respectively, while co-
infection was present in 33% of patients. CagPAI was present in only 20% of patients with GCA 
and in 9% of patients with NGD. As regards vacA alleles, s2i2m2 were predominant, present in 
80% and 82% of patients with CGA and NGD respectively. The status “ON” of oipA gene was 
present in the same percentage. Finally, we found that 38% of patients positive for H. pylori 
infection showed resistance to Clarithromycin. In our study, there was a strong association between 
the simultaneous presence of H. pylori and EBV infection in patients with CGA compared to 
patients with NGD. Furthermore, our data confirmed the high percentage of resistance among H. 
pylori strains circulating in Sicily, underlining the importance of establishing a therapy that is 
effective in eradicating them and reducing the frequency of coinfections and evolution towards 
gastric cancerogenesis.
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Introduction 
In recent years infections involving bacteria and 
viruses have been associated with the 
development of gastric diseases such as gastric 
cancer (GC), chronic gastritis and MALT 
Lymphoma [1].  
In particular, the role of Helicobacter pylori and 
Epstein-Barr virus (EBV) in gastric 
cancerogenesis has been assessed [1-5]. In the 
past the authors have shown that Helicobacter 
pylori can produce a Helicobacter-like 
vacuolating toxin and may be responsible for 
cases of childhood diarrhea [3].  
H. pylori was defined as a group 1 carcinogen 
in 1994 by the International Agency for Research 
on Cancer, while EBV maintains its genome 
inside host cells avoiding cell death and evading 
the immune system [6,7]. Nowadays, the role of 
EBV infection in inflammatory gastro intestinal 
disease is emerging and under debate 8-10.  
The virulence factors of H. pylori are mainly 
involved in the development of gastric diseases; 
among these are the genes cagA, vacA and oipA. 
CagA is the most extensively studied H. pylori 
virulence factor and it is a polymorphic gene [11]. 
There are diverse numbers of repeat sequences 
located in the 3′ region of the gene. All repeat 
regions of the CagA protein contain Glu-Pro-Ile-
Tyr-Ala (EPIYA) motifs. VacA is the next most 
considered H. pylori virulence factor. Three 
different regions are known in the vacA gene 
structure, at the signal (s) region (s1 and s2), 
intermediate (i) region (i1 and i2) and the middle 
(m) region (m1 and m2) [11]. 
Finally, OipA was recognized as a 
proinflammatory-response-inducing protein, 
conditioning the production of IL-8 from gastric 
epithelial cells [12]. It is clear that the eradication 
of the bacterium appears to decrease the 
frequency of gastric  cancer  in  high risk  patients 
[13]. In particular, resistance to Clarithromycin, a 
key drug used for eradication, may have an 
influence on the efficiency of eradication schemes 
[14]. The point mutations in 23S rRNAgene 
explain common clarithromycin resistance [15].  
EBV infects cells from the oropharynx and then 
extends to the lymphoid tissue where it infects B 
lymphocytes [16]. Prevalence of the agent 
responsible for mononucleosis syndrome has been 
assessed in different geographic areas 17,18. 
In vitro and in vivo studies have been 
formulated on the viral interaction between EBV 
and autoimmune disorders and as a pathogenic 
mechanism in Multiple Sclerosis (MS) 19,21. 
Recently, secondary hemophagocytic 
lymphohistiocytosis (HLH) characterized by 
histiocyte proliferation and hemophagocytosis 
described by Cascio et al. in severe infection [22-
25] was also reported in patients with 
mononucleosis syndrome 25. 
The relevance of inflammatory response is 
hypothesized by recent studies that showed how 
H. pylori and EBV co-infection can cause injury 
to the tissue through inflammatory reactions or 
through more contact between CagA protein of H. 
pylori and EBV supporting augmented activation 
of B cells transiting through the gastric mucosa 
[26]. 
This study aimed to evaluate the frequency of 
H. pylori and EBV infection, as well as the 
presence of cagA, vacA and oipA genes and the 
percentage of resistance to Clarithromycin in 
gastric biopsies from adult patients with and 
without gastric disease in Sicily. 
Materials and Methods  
Patients  
Twenty-four gastric biopsies were collected 
from patients with chronic gastritis active (CGA) 
and from 24 adult patients without any gastric 
diseases (NGD) undergoing upper gastrointestinal 
endoscopy. Data and clinical information, such as 
age, sex, symptoms, clinical diagnosis and 
histology evaluation were collected; data are 
shown in Table 1. Patients under antibiotic or 
antacid treatment were omitted from the study.  
Two biopsies were collected from each patient: 
one biopsy from the antrum was used for 
molecular detection of H. pylori, cagA status, 
vacA genotyping, status of oipA and EBV through 
polymerase chain reaction (PCR). The other 
biopsy was for histological analysis. 
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DNA extraction 
The genomic DNA was extracted by means of 
QIAamp DNA Mini Kits (QIAGEN), in 
agreement with the producer’s information [27]. 
Polymerase chain reaction (PCR) 
DNA of H. pylori was detected in biopsies by 
PCR using ureaseA primers according to Fasciana 
et al. [14]. 
Instead, the BAMHI-W fragment region of the 
EBV genome was used as the target to evaluate 
the presence of the virus according to P. Di Carlo 
et al. [28].   
Positive samples for H. pylori were analysed 
with PCR in order to define the cagAstatus, the 
EPIYA motif, vacA s, i and m subtypes, oipA 
status and presence of point mutation in the 23S 
rRNA gene using specific primers, as previously 
reported [13,14]. 
Results 
We found that H. pylori and EBV presence 
occurred in 42% of patients while dual prevalence 
of H. pylori infection and EBV-DNA was 
detected in 54% of the patients with CGA. In 
patients with NGD we found that H. pylori and 
EBV infection was present in 46% and in 21% of 
patients respectively, while co-infection was 
present in 33% of patients. In Table 2 we show 
the percentage of infections related to sex of the 
patients.  
The assessment of vacA gene mosaicism in 
patients with GCA has revealed: alleles s2i2m2 in 
80% of the cases, alleles s1i1m2 in 10% of cases, 
and alleles s1i1m1 in 10% of cases. In patients 
with NGD alleles s2i2m2 were found in 82% of 
the cases, alleles s1i1m2 in 9% of cases, and 
alleles s1i1m1 in 9% of cases. The cagA gene was 
present, with EPIYA motif ABC, in only 20% of 
patients with GCA, and in 9% of patients with 
NGD with a EPIYA motif ABCC.  
The distribution of vacA mosaicism, presence 
of cagA gene motif EPIYA and status of oipA 
gene of strains related to diagnosis is shown in 
Table 3.  
Finally, the status “OFF” of gene oipA was 
present in 80% of patients with GCA and in 90% 
of patients with NGD. We also evaluated the 
presence of CTAA nucleotides that may influence 
the status of genes. CT patterns and their 
distribution are shown in Table 4.  
The analysis of the 23S rRNA gene revealed 
that 38% of patients were infected with H. pylori 
resistant to Clarithromycin and the predominant 
point mutation observed was A2142G in 7 cases 
(88 %) and A2143G in 1 case (12%). 
Conclusion 
H. pylori and EBV infections are acquired 
during childhood, and both microorganisms can 
cooperate to induce the alteration of gastric 
mucosa.  
After preliminary infection by H. pylori, 
patients can develop acute gastritis, and clinical 
outcome is determined by the diverse interactions 
between host factors and bacteria.   
In our study, H. pylori infection was present in 
43% of all patients enrolled, with a percentage of 
41% in patients with GCA and 45% in patients 
with NGD respectively.  
The three central H. pylori genes associated 
with pathogenicity are: cagA, vacA and oipA. 
Here, the presence of cagA genotype was lower 
compared to a previous study conducted in Sicily, 
and it is associated with motif EPIYA ABC in 
66% of the cases and with motif EPIYA ABCC in 
34% of the cases. Moreover, cagA gene is only 
associated with s1i1m1 or s1i1m2 mosaicism of 
the vacA gene [13,14]. 
Lastly, the status “OFF” of gene oipA, 
established through the number of repeat CT and 
based on the presence or not of CTAA, was 
present in 80% of the patients with GCA and in 
90% of patients with NGD. 
A close correlation was found between the 
status of the oipA, vacA and cagA genes and, 
indeed, the ‘on’ status occurred in cagA-positive 
strains, being associated with s1m1 mosaicism. 
The described high prevalence of H. pylori 
resistant to antibiotics suggests that empirical 
therapy with clarithromycin should be
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abandoned in Sicily, confirmed by the result of 
our study [14].  
In conclusion, the authors suggest the 
recruitment of a multidisciplinary team to assist 
with diagnostic microbiological goals in the 
different steps of EBV and H. pylori infection, 
such as morphological and imaging 
methodologies in the acute phase and during 
follow up, especially for the frail population, such 
as patients with gastrointestinal disorders and/or 
neoplasms 35-38. 
Around 31% of our patients presented EBV 
DNA in gastric biopsies, with a percentage of 
46% in patients with GCA and 21% in patients 
with NGD separately.  
The dual prevalence of H. pylori infection and 
EBV-DNA was present in 54% of the patients 
with CGA and in 33% of patients with NGD.  
Our results suggest that co-infection is more 
frequent in patients with gastric lesions, although 
additional investigations are still required to 
hypothesize a critical role of the two 
microorganisms in the development of gastric 
disease in the Italian population. 
Recently studies have suggested that 
microbiology analysis should be complemented 
with direct visualization, such as per cyto- and/or 
histo-pathology analysis, especially when samples 
are obtained from unsterile sites, for example 
gastrointestinal and respiratory apparatus 35-38. 
In conclusion, the authors encourage 
researchers to apply existing and newly acquired 
knowledge within a multi-disciplinary team 
investigation using radiological and 
morphological investigations 37,38 for a more 
clinical amplification of microbiological features 
of the gastrointestinal tract, 39-41.   
The promise of prevention through vaccination 
is the goal of virologist researchers. The authors 
currently encourage health promotion through 
standardized vaccine schedules 42,43. 
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Table 1. Clinical and histology diagnosis, sex and age of patients enrolled. 
 
Diagnosis Male (%)  Female (%) Medium age  Range of age  
CGA 37.5% (9/24) 62.5% (15/24)  47 22-87 
NGD 33.3% (8/24) 66.7% (16/24) 45,7 25-71 
 
Table 2. The percentage of infections related to sex of patients 
Diagnosis/Sex Patients H.p+ (%) Patients  EBV+ (%) Patients  H.p+/EBV+ (%) 
GCA    
Male 33.3% (3/9) 33.3% (3/9) 2.2% (2/9) 
Female 46.7% (7/15) 46.7% (7/15) 33.3% (5/15) 
NGD    
Male 37.5% (3/8) 12.5% (1/8) 12.5% (1/8) 
Female 50.0% (8/16) 25.0% (4/16) 18.75% (3/16) 
 
Table 3. Distribution of vacA mosaicism, presence of cagA gene motif EPIYA and status of oipA gene. 
Diagnosis 
vacA mosaicism 
Nr. (%) 
cagA Positive/ motif EPIYA 
Nr. (%) 
CagA Negative 
Nr. (%) 
Status oipA 
Nr. (%) 
GCA 
s2i2m2 
8 (80%) 
- 8 (82%) 
OFF 
8 (80%) 
s1i1m2 
1 (10%) 
1 (10%) 
ABC 
- 
ON 
1 (10%) 
s1i1m1 
1 (10%) 
1 (10%) 
ABC 
- 
ON 
1 (10%) 
NGD 
s2i2m2 
9 (82%) 
- 9 (82%) 
OFF 
9 (82%) 
s1i1m2 
1 (9%) 
- 1 (9%) 
OFF 
1 (9%) 
s1i1m1 
1 (9%) 
1 (9 %) 
ABCC 
- 
ON 
1 (9 %) 
GCA=chronic gastritis active; NGD=without gastric disease. 
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Table 4. oipA CT repeat patterns 
Sequence of signal peptide-encoding region of oipA Nr. CT Nr. of strains 
OFF Status   
ATGAAAAAAGCTCTCTTA……...CTCTCTCTCTCTCTCTCTCGTT 9 4 
ATGAAAAAAGCCCTCTTACTAACTCTCTCTCTCTCTCTCGTTT 8 5 
ATGAAAAAAGCTCTCTTGCTAACTCTCTCTCTCTCTCTCTCTCGTT 10 4 
ATGAAAAAAGCTCTTTTA………CTCTCTCTCTCTCGTT 6 1 
ATGAAAAAAGCTCTCTTACTAACTCTCTCTCTCTCTCGTT  7 2 
ATGAAAAAGCTCTCTTA………CTCTCTCTCTCTCTCGTTCTGG  7 1 
ATGAAAAAAGCCCTCTTA……..CTCTCTCTTTCTCTCGTTTT 4+2 1 
ON Status   
ATGAAAAAAGCTCTCTTACTAATTCTCTCTCTCTCGTT 5 1 
ATGAAAAAAGCTCTCTTACTAACTCTCTCTCTCTCGTT 6 1 
ATGAAAAAAGCCCTCTTA……..CTCTCTCTCTCTCTCTCTCTCTCGT 11 1 
 
 
 
